Anthropic says it disrupted five cases in which users attempted to employ its Claude models for work that could support biological weapons development. Two cases involved researchers seeking assistance with gain-of-function experiments on dangerous viruses.

Its assessment instead found that sophisticated actors, including suspected state-linked researchers, were conducting dual-use biological work while evading access controls. Because the same techniques can support legitimate medical research or weapon development, intent remains hard to determine.

Anthropic has added restrictions to its newest models for biological questions that could be misused. The company said stronger protection will also require account verification, institutional credentials, and retained activity data capable of identifying suspicious behavior.

The disclosure follows rapid advances in AI-assisted biology. A Stanford team recently used generative AI to design a synthetic virus that does not occur in nature. Researchers say current systems can predict pathogen evolution, design viral genomes, and create genetic sequences capable of bypassing screening software. Those capabilities are driving calls for federal safety reviews before releasing increasingly powerful biological models.

Biological weapons have traditionally required a high barrier to access, from years of specialized training to secure laboratories. But AI is adding shortcuts to the process by helping users to better interpret research and solve technical problems, in turn allowing them to design genetic material faster and more efficiently than they could before…

One of 2026's most talked about robots, Flippy Fry Station, was spotted secretly cozying up with even more fast-food restaurant A-listers! 

First was iconic burger brand, White Castle. 

Then, Flippy-creator Miso Robotics’ newest tech was seen sneaking around with Jersey Mike's, Cinnabon, and Auntie Anne's. 

In fact, rumor now has it that Flippy and Miso have taken this torrid streak outside the restaurant world! They’ve even been spotted working their way through college campuses and an NBA arena.

Robot tabloids can’t wait to see who will be next! 

Everyday people have already made 44k+ investments into Miso. Industry powerhouse Ecolab even invested.*

Now’s your chance, too. But hurry. Invest at $5.48/share before it changes on 9/17.

The involvement of suspected state actors makes this a national security issue rather than a technology dispute. Foreign governments can conceal researchers behind accounts, making content filters alone inadequate.

Moving forward, leaders in Washington must avoid rules that cripple legitimate research or leave American laboratories behind competitors in China, as AI can accelerate drug discovery, disease surveillance, and vaccine development when used properly. The policy challenge is separating beneficial work from activity that creates unacceptable risk.

Voluntary company controls are unlikely to be enough when models and biological tools are spreading across borders. Federal standards would set a threshold for testing systems before release, rather than relying on developers to decide how much danger is acceptable.

Access to advanced biological AI models may soon be much more restrictive given the nature of the work. Scientists studying dangerous pathogens could be required to verify their identity and institutional affiliation, while providers retain activity records to detect misuse. Those controls would make anonymous abuse harder, while also putting legitimate research under closer scrutiny.

Patients should have a vested interest in preserving the benefits, as the same systems that could assist bioweapons research can help identify drug candidates, anticipate viral mutations, and shorten vaccine development. Restrictions written too vaguely could delay discoveries, while weak controls could expose the public to a threat created by someone using software and rented laboratory services.

While bringing more federal authority into the mix would add another variable, but industry leaders have repeatedly warned of the risk and called for more federal oversight and authority to deactivate a model capable of catastrophic harm. The standard for using this power must be defined, and lawmakers and industry leaders alike are calling for more independent testing moving forward.

The goal is not to keep AI out of biology; used correctly, artificial intelligence has the potential to do exceptional work. However, there needs to be an assurance that these tools capable of improving public health cannot quietly become a shortcut for creating the next pandemic.

*Disclaimer: This is a paid advertisement for Miso Robotics’ Regulation A offering. Please read the offering circular at invest.misorobotics.com